Cargando…
Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the foref...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775979/ https://www.ncbi.nlm.nih.gov/pubmed/36551781 http://dx.doi.org/10.3390/biomedicines10123025 |
_version_ | 1784855765615378432 |
---|---|
author | Arnst, Nikita Redolfi, Nelly Lia, Annamaria Bedetta, Martina Greotti, Elisa Pizzo, Paola |
author_facet | Arnst, Nikita Redolfi, Nelly Lia, Annamaria Bedetta, Martina Greotti, Elisa Pizzo, Paola |
author_sort | Arnst, Nikita |
collection | PubMed |
description | Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the forefront the “calcium (Ca(2+)) hypothesis” as a key AD pathogenic pathway, impacting neuronal, astrocyte and microglial function. In this review, we focused on mitochondrial Ca(2+) alterations in AD, their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca(2+) signals to neuronal death in different experimental AD models. |
format | Online Article Text |
id | pubmed-9775979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97759792022-12-23 Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease Arnst, Nikita Redolfi, Nelly Lia, Annamaria Bedetta, Martina Greotti, Elisa Pizzo, Paola Biomedicines Review Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the forefront the “calcium (Ca(2+)) hypothesis” as a key AD pathogenic pathway, impacting neuronal, astrocyte and microglial function. In this review, we focused on mitochondrial Ca(2+) alterations in AD, their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca(2+) signals to neuronal death in different experimental AD models. MDPI 2022-11-24 /pmc/articles/PMC9775979/ /pubmed/36551781 http://dx.doi.org/10.3390/biomedicines10123025 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Arnst, Nikita Redolfi, Nelly Lia, Annamaria Bedetta, Martina Greotti, Elisa Pizzo, Paola Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease |
title | Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease |
title_full | Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease |
title_fullStr | Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease |
title_full_unstemmed | Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease |
title_short | Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease |
title_sort | mitochondrial ca(2+) signaling and bioenergetics in alzheimer’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775979/ https://www.ncbi.nlm.nih.gov/pubmed/36551781 http://dx.doi.org/10.3390/biomedicines10123025 |
work_keys_str_mv | AT arnstnikita mitochondrialca2signalingandbioenergeticsinalzheimersdisease AT redolfinelly mitochondrialca2signalingandbioenergeticsinalzheimersdisease AT liaannamaria mitochondrialca2signalingandbioenergeticsinalzheimersdisease AT bedettamartina mitochondrialca2signalingandbioenergeticsinalzheimersdisease AT greottielisa mitochondrialca2signalingandbioenergeticsinalzheimersdisease AT pizzopaola mitochondrialca2signalingandbioenergeticsinalzheimersdisease |